08-04 Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating MT
08-03 UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating MT
08-03 Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating MT
07-31 DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised MT
07-31 DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says MT
07-31 Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating MT
07-31 RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating MT
07-31 Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating MT
07-31 Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating MT
07-31 Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating MT
07-31 Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating MT
07-31 Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating MT
07-31 Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating MT
07-31 Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating MT
07-31 Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating MT
07-31 JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating MT
07-31 Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating MT
07-31 Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating MT
07-31 Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating MT
07-31 Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating MT
07-31 Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating MT
07-31 BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating MT
07-31 Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating MT
07-30 DexCom, Inc., Q2 2026 Earnings Call, Jul 30, 2026
07-30 DexCom, Inc. Raises Earnings Guidance for the Fiscal Year 2026 CI
No results match your criteria